Antiretroviral resistance in hiv 1. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

CD4-Positive T-Lymphocytes Plasma CD8-Positive T-Lymphocytes Cell Line Cell Line, Tumor Cells, Cultured Leukocytes, Mononuclear

Organisms7

HIV-1 HIV Escherichia coli HIV-2 Simian immunodeficiency virus Staphylococcus aureus Mycobacterium tuberculosis

Diseases26

HIV Infections HIV Seropositivity Acquired Immunodeficiency Syndrome AIDS-Related Opportunistic Infections Disease Resistance HIV-Associated Lipodystrophy Syndrome Pregnancy Complications, Infectious Viremia AIDS Dementia Complex Coinfection Immune Reconstitution Inflammatory Syndrome Tuberculosis Lipodystrophy Substance Abuse, Intravenous HIV Wasting Syndrome Lymphoma, AIDS-Related Disease Progression Cytomegalovirus Retinitis Hepatitis C AIDS-Associated Nephropathy Tuberculosis, Pulmonary Acidosis, Lactic Sarcoma, Kaposi Tuberculosis, Multidrug-Resistant Simian Acquired Immunodeficiency Syndrome Substance-Related Disorders

Chemicals and Drugs64

Anti-HIV Agents Anti-Retroviral Agents HIV Protease HIV Reverse Transcriptase Reverse Transcriptase Inhibitors RNA, Viral HIV Protease Inhibitors Zidovudine Nevirapine Benzoxazines Stavudine Organophosphonates Ritonavir Anti-Bacterial Agents Lamivudine Lopinavir Adenine Indinavir Pyrimidinones Nelfinavir Didanosine Antitubercular Agents Dideoxynucleosides Antiviral Agents HIV Antigens HIV Integrase Inhibitors Saquinavir HIV Fusion Inhibitors Oxazines pol Gene Products, Human Immunodeficiency Virus Bacterial Proteins HIV Core Protein p24 P-Glycoprotein Anti-Infective Agents Pyrrolidinones DNA, Bacterial HIV Envelope Protein gp120 DNA, Viral HIV Envelope Protein gp41 Trimethoprim-Sulfamethoxazole Combination Receptors, HIV Protease Inhibitors Tetracycline Drug Combinations Receptors, CCR5 Cyclohexanes Insulin Multidrug Resistance-Associated Proteins Rifampin Antineoplastic Agents Erythromycin Streptomycin Biological Markers Integrase Inhibitors HIV Integrase Sulfonamides ATP-Binding Cassette Transporters Carbamates Macrolides beta-Lactamases Pyridines Blood Glucose Isoniazid Antimalarials

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Antiretroviral Therapy, Highly Active Viral Load Treatment Failure CD4 Lymphocyte Count Drug Therapy, Combination Cohort Studies Microbial Sensitivity Tests Treatment Outcome HIV Seroprevalence Prevalence Risk Factors Lost to Follow-Up Cross-Sectional Studies Prospective Studies Drug Monitoring Drug Administration Schedule AIDS Serodiagnosis Retrospective Studies Directly Observed Therapy Airway Resistance Sequence Analysis, DNA Follow-Up Studies Resistance Training Incidence Polymerase Chain Reaction Longitudinal Studies Multivariate Analysis CD4-CD8 Ratio Logistic Models Chemoprevention Withholding Treatment Reverse Transcriptase Polymerase Chain Reaction Lymphocyte Count Pilot Projects Models, Biological Proportional Hazards Models Case-Control Studies Survival Analysis Regression Analysis Condoms Questionnaires Population Surveillance Clinical Trials as Topic Flow Cytometry

Psychiatry and Psychology16

Medication Adherence Patient Compliance AIDS Dementia Complex Sexual Behavior Homosexuality, Male Substance Abuse, Intravenous Risk-Taking Treatment Refusal Counseling Health Knowledge, Attitudes, Practice Social Stigma Heterosexuality Unsafe Sex Substance-Related Disorders Stereotyping Safe Sex

Phenomena and Processes55

Drug Resistance, Viral Viral Load Drug Resistance, Multiple, Viral Genotype Mutation CD4 Lymphocyte Count Drug Resistance Drug Resistance, Microbial Drug Resistance, Bacterial Drug Resistance, Neoplasm Drug Resistance, Multiple Disease Resistance Vascular Resistance Drug Resistance, Multiple, Bacterial HIV Seronegativity Time Factors Tetracycline Resistance Virus Replication Plant Diseases Penicillin Resistance Pregnancy Drug Resistance, Fungal Airway Resistance Homosexuality, Male beta-Lactam Resistance Immunity, Innate Phenotype Resistance Training Base Sequence Amino Acid Sequence R Factors Drug Interactions Mutation, Missense Ampicillin Resistance Chloramphenicol Resistance Plasmids CD4-CD8 Ratio Phylogeny Genes, Bacterial Genes, pol Conjugation, Genetic Methicillin Resistance Lymphocyte Count Cephalosporin Resistance Virus Latency Dose-Response Relationship, Drug Viral Tropism Kanamycin Resistance Herbicide Resistance Vancomycin Resistance Genes, MDR Genetic Variation Heterosexuality Signal Transduction Apoptosis

Anthropology, Education, Sociology and Social Phenomena4

Developing Countries Resistance Training Treatment Refusal Socioeconomic Factors

Information Science7

Molecular Sequence Data Prevalence Incidence Base Sequence Amino Acid Sequence Phylogeny Questionnaires

Named Groups5

HIV Long-Term Survivors Infant, Newborn Sexual Partners Drug Users Prisoners

Health Care38

Treatment Failure Medication Adherence Infectious Disease Transmission, Vertical Cohort Studies Patient Compliance Treatment Outcome HIV Seroprevalence Prevalence Risk Factors Cross-Sectional Studies Prospective Studies Retrospective Studies Follow-Up Studies Incidence Longitudinal Studies Multivariate Analysis Health Services Accessibility Epidemics Rural Population Logistic Models Treatment Refusal Counseling Withholding Treatment Health Knowledge, Attitudes, Practice Ambulatory Care Facilities Socioeconomic Factors Pilot Projects Proportional Hazards Models Case-Control Studies World Health Organization Survival Analysis Regression Analysis Questionnaires Population Surveillance Health Resources Clinical Trials as Topic Patient Acceptance of Health Care Age Factors

Geographicals27

Lesotho South Africa Uganda Malawi Africa South of the Sahara Botswana Zambia Cote d'Ivoire Zimbabwe Thailand Kenya India Cameroon Africa, Southern United States Rwanda Tanzania Africa Brazil Haiti Mozambique Cambodia British Columbia Ethiopia San Francisco China Namibia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Drug Resistance, Viral HIV Infections Anti-HIV Agents Antiretroviral Therapy, Highly Active Lesotho Anti-Retroviral Agents HIV-1 HIV Protease HIV Reverse Transcriptase Viral Load Drug Resistance, Multiple, Viral Reverse Transcriptase Inhibitors Treatment Failure RNA, Viral Genotype Mutation CD4 Lymphocyte Count Drug Resistance HIV Seropositivity Drug Resistance, Microbial Drug Resistance, Bacterial HIV Protease Inhibitors Acquired Immunodeficiency Syndrome Drug Resistance, Neoplasm HIV South Africa Zidovudine Drug Resistance, Multiple Nevirapine AIDS-Related Opportunistic Infections Medication Adherence Disease Resistance Benzoxazines Stavudine Vascular Resistance Infectious Disease Transmission, Vertical Drug Therapy, Combination Organophosphonates Drug Resistance, Multiple, Bacterial Ritonavir Cohort Studies HIV Seronegativity Uganda Patient Compliance Microbial Sensitivity Tests Anti-Bacterial Agents Lamivudine HIV-Associated Lipodystrophy Syndrome Treatment Outcome Lopinavir Adenine CD4-Positive T-Lymphocytes HIV Seroprevalence Pregnancy Complications, Infectious Indinavir Viremia Malawi AIDS Dementia Complex Time Factors Pyrimidinones Nelfinavir Coinfection Molecular Sequence Data Prevalence Immune Reconstitution Inflammatory Syndrome Risk Factors Didanosine Lost to Follow-Up Africa South of the Sahara Botswana Antitubercular Agents Tetracycline Resistance Cross-Sectional Studies Prospective Studies Virus Replication Dideoxynucleosides Zambia Cote d'Ivoire Zimbabwe Drug Monitoring Plant Diseases Drug Administration Schedule Penicillin Resistance AIDS Serodiagnosis Antiviral Agents Pregnancy Retrospective Studies Tuberculosis Drug Resistance, Fungal Directly Observed Therapy Sexual Behavior Airway Resistance HIV Antigens Homosexuality, Male Lipodystrophy HIV Integrase Inhibitors Substance Abuse, Intravenous Sequence Analysis, DNA Developing Countries HIV Long-Term Survivors

No FAQ available that match "antiretroviral resistance in hiv 1"